Lappe Mark
Inhibrx Biosciences, Inc. · Chief Executive Officer
Lappe Mark is listed in filings as Chief Executive Officer at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through Sep 16, 2024, including purchase activity. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX). The current snapshot covers public activity from Sep 10, 2024 to Sep 16, 2024. Reported amounts are shown as $223.3K to $129.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $406k27k shares | BuySep 12, 2024 | $15.05 | $89.07 | |
| $129k8.5k shares | BuySep 10, 2024 | $15.19 | $89.07 | |
| $144k9.5k shares | BuySep 9, 2024 | $15.21 | $89.07 | |
| $398k26k shares | BuySep 6, 2024 | $15.29 | $89.07 |